Today's Good Vibe — 2026-08-21
Experimental Drug Shows Promise in Preventing Pancreatic Cancer in High-Risk Patients
Johns Hopkins researchers found an experimental drug safe for humans that generates durable immune responses against key pancreatic cancer drivers. The trial offers new hope for preventing one of the deadliest cancers.
Why it feels good
Targeted preventive therapy could significantly improve early defense against a disease long considered extremely difficult to detect and treat early.